183 related articles for article (PubMed ID: 30910317)
21. A multicentre comparative prospective blinded analysis of EUS and MRI for screening of pancreatic cancer in high-risk individuals.
Harinck F; Konings IC; Kluijt I; Poley JW; van Hooft JE; van Dullemen HM; Nio CY; Krak NC; Hermans JJ; Aalfs CM; Wagner A; Sijmons RH; Biermann K; van Eijck CH; Gouma DJ; Dijkgraaf MG; Fockens P; Bruno MJ;
Gut; 2016 Sep; 65(9):1505-13. PubMed ID: 25986944
[TBL] [Abstract][Full Text] [Related]
22. Value of EUS in early detection of pancreatic ductal adenocarcinomas in patients with intraductal papillary mucinous neoplasms.
Kamata K; Kitano M; Kudo M; Sakamoto H; Kadosaka K; Miyata T; Imai H; Maekawa K; Chikugo T; Kumano M; Hyodo T; Murakami T; Chiba Y; Takeyama Y
Endoscopy; 2014 Jan; 46(1):22-9. PubMed ID: 24218310
[TBL] [Abstract][Full Text] [Related]
23. Pancreatic cysts: What imaging characteristics are associated with development of pancreatic ductal adenocarcinoma?
Paroder V; Flusberg M; Kobi M; Rozenblit AM; Chernyak V
Eur J Radiol; 2016 Sep; 85(9):1622-6. PubMed ID: 27501898
[TBL] [Abstract][Full Text] [Related]
24. Pancreatic duct "Icicle sign" on MRI for distinguishing autoimmune pancreatitis from pancreatic ductal adenocarcinoma in the proximal pancreas.
Kim HJ; Kim YK; Jeong WK; Lee WJ; Choi D
Eur Radiol; 2015 Jun; 25(6):1551-60. PubMed ID: 25501271
[TBL] [Abstract][Full Text] [Related]
25. Endoscopic approach in the diagnosis of high-grade pancreatic intraepithelial neoplasia.
Hanada K; Shimizu A; Kurihara K; Ikeda M; Yamamoto T; Okuda Y; Tazuma S
Dig Endosc; 2022 Jul; 34(5):927-937. PubMed ID: 35165942
[TBL] [Abstract][Full Text] [Related]
26. Prevalence and Progression of Pancreatic Cystic Precursor Lesions Differ Between Groups at High Risk of Developing Pancreatic Cancer.
Konings IC; Harinck F; Poley JW; Aalfs CM; van Rens A; Krak NC; Wagner A; Nio CY; Sijmons RH; van Dullemen HM; Vleggaar FP; Ausems MG; Fockens P; van Hooft JE; Bruno MJ;
Pancreas; 2017 Jan; 46(1):28-34. PubMed ID: 27846136
[TBL] [Abstract][Full Text] [Related]
27. Identification and Validation of a Biomarker Signature in Patients With Resectable Pancreatic Cancer via Genome-Wide Screening for Functional Genetic Variants.
Dimitrakopoulos C; Vrugt B; Flury R; Schraml P; Knippschild U; Wild P; Hoerstrup S; Henne-Bruns D; Wuerl P; Graf R; Breitenstein S; Bond G; Beerenwinkel N; Grochola LF
JAMA Surg; 2019 Jun; 154(6):e190484. PubMed ID: 30942874
[TBL] [Abstract][Full Text] [Related]
28. Dilemmas in the management of screen-detected lesions in patients at high risk for pancreatic cancer.
Ibrahim IS; Bonsing BA; Swijnenburg RJ; Welling L; Veenendaal RA; Wasser MN; Morreau H; Inderson A; Vasen HF
Fam Cancer; 2017 Jan; 16(1):111-115. PubMed ID: 27406244
[TBL] [Abstract][Full Text] [Related]
29. Automatic Detection of Pancreatic Lesions and Main Pancreatic Duct Dilatation on Portal Venous CT Scans Using Deep Learning.
Abi Nader C; Vetil R; Wood LK; Rohe MM; Bône A; Karteszi H; Vullierme MP
Invest Radiol; 2023 Nov; 58(11):791-798. PubMed ID: 37289274
[TBL] [Abstract][Full Text] [Related]
30. Clinical features and prognostic impact of asymptomatic pancreatic cancer.
Takikawa T; Kikuta K; Hamada S; Kume K; Miura S; Yoshida N; Tanaka Y; Matsumoto R; Ikeda M; Kataoka F; Sasaki A; Nakagawa K; Unno M; Masamune A
Sci Rep; 2022 Mar; 12(1):4262. PubMed ID: 35277545
[TBL] [Abstract][Full Text] [Related]
31. Clinical Features and Prognostic Impact of Pancreatic Ductal Adenocarcinoma without Dilatation of the Main Pancreatic Duct: A Single-Center Retrospective Analysis.
Takayanagi T; Sekino Y; Kasuga N; Ishii K; Nagase H; Nakajima A
Diagnostics (Basel); 2023 Mar; 13(5):. PubMed ID: 36900107
[TBL] [Abstract][Full Text] [Related]
32. Burden of hereditary cancer susceptibility in unselected patients with pancreatic ductal adenocarcinoma referred for germline screening.
Cremin C; Lee MK; Hong Q; Hoeschen C; Mackenzie A; Dixon K; McCullum M; Nuk J; Kalloger S; Karasinska J; Scudamore C; Kim PTW; Donnellan F; Lam ECS; Lim HJ; Neben CL; Stedden W; Zhou AY; Schaeffer DF; Sun S; Renouf DJ; Schrader KA
Cancer Med; 2020 Jun; 9(11):4004-4013. PubMed ID: 32255556
[TBL] [Abstract][Full Text] [Related]
33. Management of branch-duct intraductal papillary mucinous neoplasms: a large single-center study to assess predictors of malignancy and long-term outcomes.
Ridtitid W; DeWitt JM; Schmidt CM; Roch A; Stuart JS; Sherman S; Al-Haddad MA
Gastrointest Endosc; 2016 Sep; 84(3):436-45. PubMed ID: 26905937
[TBL] [Abstract][Full Text] [Related]
34. Surveillance for pancreatic cancer in high-risk individuals.
Konings ICAW; Canto MI; Almario JA; Harinck F; Saxena P; Lucas AL; Kastrinos F; Whitcomb DC; Brand RE; Lachter J; Malleo G; Paiella S; Syngal S; Saltzman JR; Stoffel EM; van Hooft JE; Hruban RH; Poley JW; Fockens P; Goggins MG; Bruno MJ;
BJS Open; 2019 Oct; 3(5):656-665. PubMed ID: 31592073
[TBL] [Abstract][Full Text] [Related]
35. Focal ductal branch dilatation on magnetic resonance cholangiopancreatography: a hint for early diagnosis of pancreatic carcinoma.
Yokohata K; Shirahane K; Yonemasu H; Nabae T; Inoue K; Ohtsuka T; Yamaguchi K; Chijiiwa K; Tanaka M
Scand J Gastroenterol; 2000 Nov; 35(11):1229-32. PubMed ID: 11145298
[TBL] [Abstract][Full Text] [Related]
36. Prediction of Pancreatic Cancer Based on Imaging Features in Patients With Duct Abnormalities.
Chen W; Butler RK; Zhou Y; Parker RA; Jeon CY; Wu BU
Pancreas; 2020 Mar; 49(3):413-419. PubMed ID: 32132511
[TBL] [Abstract][Full Text] [Related]
37. Refinement of screening for familial pancreatic cancer.
Bartsch DK; Slater EP; Carrato A; Ibrahim IS; Guillen-Ponce C; Vasen HF; Matthäi E; Earl J; Jendryschek FS; Figiel J; Steinkamp M; Ramaswamy A; Vázquez-Sequeiros E; Muñoz-Beltran M; Montans J; Mocci E; Bonsing BA; Wasser M; Klöppel G; Langer P; Fendrich V; Gress TM
Gut; 2016 Aug; 65(8):1314-21. PubMed ID: 27222532
[TBL] [Abstract][Full Text] [Related]
38. Main pancreatic duct intraductal papillary mucinous neoplasms: accuracy of MR imaging in differentiation between benign and malignant tumors compared with histopathologic analysis.
Manfredi R; Graziani R; Motton M; Mantovani W; Baltieri S; Tognolini A; Crippa S; Capelli P; Salvia R; Pozzi Mucelli R
Radiology; 2009 Oct; 253(1):106-15. PubMed ID: 19703865
[TBL] [Abstract][Full Text] [Related]
39. The natural history of main duct-involved, mixed-type intraductal papillary mucinous neoplasm: parameters predictive of progression.
Roch AM; Ceppa EP; Al-Haddad MA; DeWitt JM; House MG; Zyromski NJ; Nakeeb A; Schmidt CM
Ann Surg; 2014 Oct; 260(4):680-8; discussion 688-90. PubMed ID: 25203885
[TBL] [Abstract][Full Text] [Related]
40. Small solid tumors (< or = 2 cm) of the pancreas: relative accuracy and differentiation of CT and MR imaging.
Rao SX; Zeng MS; Cheng WZ; Yao XZ; Jin DY; Ji Y
Hepatogastroenterology; 2011; 58(107-108):996-1001. PubMed ID: 21830431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]